Increased immunogenicity of murine lymphatic tumors by pyrazole-4-carboxamide, 3 (or 5) -amino (NSC-1402; PCA)
Nicolin, A.; Vadlamudi, S.; Goldin, A.
Cancer ChemoTherapy Reports 57(1): 3-10
1973
ISSN/ISBN: 0069-0112 PMID: 4704101 Document Number: 58604
Document emailed within 1 workday
Related Documents
Ma, Q.; Wu, Y.; Yu, L. 1997: Abrogated or decreased tumorigenicity and metastasis induced by retroviral-mediated B7.1 gene transfer on murine tumors with different immunogenicity Zhonghua Yi Xue Za Zhi 77(5): 374-377Schlesinger, M.; Grossowicz, N.; Lichtenstein, N. 1971: Inhibition of murine tumors by carbobenzoxy derivatives of amino acids Israel Journal of Medical Sciences 7(4): 547-552
Husmann, M.J.; Roedel, C.; Leu, A.J.; Koppensteiner, R.; Franzeck, U.K. 1999: Lymphoedema, lymphatic microangiopathy and increased lymphatic and interstitial pressure in a patient with Parkinson's disease Schweizerische Medizinische Wochenschrift 129(10): 410-412
Vistica, D.T.; Rabon, A.; Rabinovitz, M. 1979: Amino acid conferred protection against melphalan: comparison of amino acids which reduce melphalan toxicity to murine bone marrow precursor cells (CFU-C) and murine L1210 leukemia cells Research Communications in Chemical Pathology and Pharmacology 23(1): 171-183
Fehér, V.J.; Jakab, L.; Tenczer, J.; Szilvási, I. 1977: Clinical studies on the liver-protective effect of 4-amino-5-imidazole carboxamide and orotic acid Deutsche Zeitschrift für Verdauungs- und Stoffwechselkrankheiten 37(4): 175-179
Yanaura, S.; Abe, Y.; Iwase, H.; Motoashi, Y.; Mineo, K. 1973: Pharmacological studies of 1,3-diphenyl-5-(2-dimethyl amino propionamide) pyrazole HCL (AP-14) with special reference to its action on the central nervous system Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 69(5): 679-687
Hadnagy, C.; Marinca, E.; Macavei, I.; Sass, G. 1986: The simultaneous occurrence of chronic lymphatic leukemia with malignant tumors and the lymphatic reaction caused by malignant growths Folia Haematologica 113(5): 633-637
Balzarini, J.; Lee, C.K.; Schols, D.; De Clercq, E. 1991: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes Biochemical and Biophysical Research Communications 178(2): 563-569
Fichtner, I.; Reipert, B.; Becker, M.; Lemm, M. 1993: In vivo characterization of immunogenicity of a mitoxantrone-resistant murine P388 leukemia In Vivo 7(1): 73-79
Miller, C.W.; DeBlasi, R.F.; Fisher, S.J. 1976: Immunological studies in murine osteosarcoma. Immunogenicity, growth kinetics, and immunotherapy Journal of Bone and Joint Surgery. American Volume 58(3): 312-317
Boon, T.; Maryanski, J. 1985: Tumour cell variants with increased immunogenicity obtained by mutagen treatment Cancer Surveys 4(1): 135-148
Linker-Israeli, M.; Haran-Ghera, N. 1975: Analysis of cell populations in murine lymphatic Israel Journal of Medical Sciences 11(12): 1380
Fioretti, M.C.; Bianchi, R.; Romani, L.; Bonmassar, E. 1983: Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity Journal of the National Cancer Institute 71(6): 1247-1251
Rosenberg, S.A.; Schwarz, S. 1974: Murine autoantibodies to a cryptic membrane antigen; possible explanation for neuraminidase-induced increase in cell immunogenicity Journal of the National Cancer Institute 52(4): 1151-1155
Reipert, B.M.; Schoppmann, A.; Schwarz, H.Peter. 2003: A caution on the use of murine hemophilia models for comparative immunogenicity studies of FVIII products with different protein compositions Thrombosis and haemostasis 89(6): 1110-2; author reply 1113
Zhong, G.; Toth, I.; Reid, R.; Brunham, R.C. 1993: Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis Journal of Immunology 151(7): 3728-3736
Morrison, B.W.; Leder, P. 1994: neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors Oncogene 9(12): 3417-3426
Knott, E.M.; Tune, J.D.; Stoll, S.T.; Downey, H.F. 2005: Increased lymphatic flow in the thoracic duct during manipulative intervention Journal of the American Osteopathic Association 105(10): 447-456
Shu, S.Y.; Chou, T.; Sakai, K. 1989: Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity Journal of Immunology 143(2): 740-748
Young, S.D.; Hill, R.P. 1990: Effects of reoxygenation on cells from hypoxic regions of solid tumors: analysis of transplanted murine tumors for evidence of DNA overreplication Cancer Research 50(16): 5031-5038